Patents by Inventor Mitchell Golbus

Mitchell Golbus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Advanced cervical cell screening methods
    Patent number: 7838215
    Abstract: Advanced cervical cancer screening methods that provide a molecular based process of detecting HPV-integration. The disclosed methods allow for a streamlined approach of conducting a Pap test and immunohistochemical test on the same slide. The disclosed methods provides an inexpensive, highly sensitive, specific, and detailed test that is easy to evaluate and follow-up.
    Type: Grant
    Filed: September 16, 2008
    Date of Patent: November 23, 2010
    Assignee: Canvir, Inc.
    Inventors: Peter Gombrich, Mitchell Golbus
  • ADVANCED CERVICAL CELL SCREENING METHODS
    Publication number: 20090104597
    Abstract: Advanced cervical cancer screening methods that provide a molecular based process of detecting HPV-integration. The disclosed methods allow for a streamlined approach of conducting a Pap test and immunohistochemical test on the same slide. The disclosed methods provides an inexpensive, highly sensitive, specific, and detailed test that is easy to evaluate and follow-up.
    Type: Application
    Filed: September 16, 2008
    Publication date: April 23, 2009
    Applicant: DIAMICS, INC.
    Inventors: Peter GOMBRICH, Mitchell GOLBUS
  • Use of anti-embryonic epsilon hemoglobin antibodies to identify fetal cells
    Patent number: 5962234
    Abstract: An in vitro method of identifying or isolating fetal cells from a blood sample is described. Fetal nucleated erythrocytes or erythroblasts are identified by using an antibody or antibody fragment specific for embryonic hemoglobin or an embryonic hemoglobin chain. Once the fetal cells are identified, they can be treated to render the fetal nucleic acids or proteins available for identification or amplification. Detecting the occurrence or existence of selected fetal nucleic acids or proteins allows a quantitative or qualitative diagnostic or prenatal evaluation, including determining the sex of the fetus, determining chromosomal, single gene or protein abnormalities, and determining the presence or absence of particular genes, nucleic acid sequences or proteins.
    Type: Grant
    Filed: September 25, 1998
    Date of Patent: October 5, 1999
    Assignee: Applied Imaging Corporation
    Inventor: Mitchell Golbus
  • Use of anti-embryonic hemoglobin antibodies to identify fetal cells
    Patent number: 5731156
    Abstract: An in vitro method of identifying or isolating fetal cells from a blood sample is described. Fetal nucleated erythrocytes or erythroblasts are identified by using an antibody or antibody fragment specific for embryonic hemoglobin or an embryonic hemoglobin chain. Once the fetal cells are identified, they can be treated to render the fetal nucleic acids or proteins available for identification or amplification. Detecting the occurrence or existence of selected fetal nucleic acids or proteins allows a quantitative or qualitative diagnostic or prenatal evaluation, including determining the sex of the fetus, determining chromosomal, single gene or protein abnormalities, and determining the presence or absence of particular genes, nucleic acid sequences or proteins.
    Type: Grant
    Filed: October 21, 1996
    Date of Patent: March 24, 1998
    Assignee: Applied Imaging, Inc.
    Inventor: Mitchell Golbus